Oxford Covid vaccine will be in India by November

Synopsis

<p>The coronavirus vaccine developed at the Oxford University will be in India by November and will ultimately cost Rs 1,000, the Indian firm partnering the UK researchers has said. The manufacturing of the Covishield vaccine had started alongwith with the clinical trials, the first phase of which got positive results. Serum Institute of India CEO Adar Poonawala told NDTV that the decision to push in 200 million dollars into an untested drug took exactly 30 minutes. The firms risks were compounded by the fact that if the clinical trials in the remaining phases do not get good results, the entire stock has to be destroyed, Poonawala said. The Serum Institute, which is the worlds largest vaccine manufacturer, said it could take up to two years to inoculate all the people in India.</p> <p>&nbsp;</p>